Recombinant Melanoma Inhibitory Activity Protein 1 (MIA1)
-
Catalog numberRPU53681-50ug
-
PricePlease ask
-
Size50ug
-
-
Estimated Turnaround Time6-11 business days
-
Gene NameNA
-
Alternative NamesCD-RAP; Melanoma-derived growth regulatory protein
-
SourceE.coli
-
Purity≥ 98%
-
ApplicationPositive Control; Immunogen; SDS-PAGE; WB.
-
Shipping ConditionsIce packs
-
Storage conditionsShort term: -20°C; Long term: -80°C. Minimize freeze and thaw cycles.
-
Shelf life1 year
-
RestrictionFor research use only. Not for diagnostic procedures.
-
Additional sourceRecombinants or rec. proteins
-
Grouprecombinants
-
Gene target
-
Gene symbolCFAP100
-
Short nameRecombinant Melanoma Inhibitory Activity Protein 1 (MIA1)
-
TechniqueRecombinant, E. coli recombinant proteins are genetic recombinations in Escherichia coli, supplied as white sterile powder lyopillized. Biomatik advises they will be reconstituted in a buffer soluion or culture medium for cell culture.
-
SpeciesMus musculus (Mouse)
-
Alternative nameRec. Melanoma Inhibitory Activity Protein 1 (MIA1)
-
Alternative techniquerec
-
Gene info
-
Identity
-
Gene
-
Long gene namecilia and flagella associated protein 100
-
Synonyms gene
-
Synonyms gene name
- coiled-coil domain containing 37
-
Synonyms
-
GenBank acession
-
Locus
-
Discovery year2005-11-02
-
Entrez gene record
-
Pubmed identfication
-
RefSeq identity
-
Classification
- Cilia and flagella associated
-
VEGA ID
MeSH Data
-
Name
-
ConceptScope note: Experimentally induced mammary neoplasms in animals to provide a model for studying human BREAST NEOPLASMS.
-
Tree numbers
- C04.588.531.500
- C04.619.590
- E05.598.500.496.843
-
Qualifiersdiagnosis, parasitology, immunology, microbiology, diagnostic imaging, physiopathology, secondary, enzymology, etiology, mortality, epidemiology, blood, cerebrospinal fluid, chemically induced, congenital, diet therapy, drug therapy, therapy, chemistry, psychology, urine, virology, history, blood supply, classification, economics, embryology, genetics, nursing, radiotherapy, prevention & control, pathology, ultrastructure, metabolism, complications, surgery